HbD Punjab also known as HbD Los Angeles is a β-chain variant and is characterized by a Glu→Gln substitution at codon 121 with a GAA→CAA change at the DNA level and the electrophotetic mobility at alkaline pH is similar to HbS (β6, Glu→Val). [1] HbD has been described in both the heterozygous and homozygous states as well as in combination with HbS or β-thalassemia. Simple heterozygous and homozygous individuals with HbD are asymptomatic, whereas association with HbS is characterized by a mild to moderate hemolytic anemia. [2] HbD-β thalassemia is also generally a very mild condition. However, HbSD disease may manifest with variable clinical features. [3] HbS and HbD are one of the commonly encountered Hb variants worldwide. [4] In India, the prevalence of HbS gene varies from 0 -34% in different tribal and some scheduled caste groups [5] whereas the average gene frequency of HbD has been observed to be 0.86% with a higher frequency of 3.6% seen in Punjab followed by Jammu and Kashmir (3.3%) and Uttar Pradesh (2.3%). [6] We describe a case of sickle cell hemoglobin 
Discussion
There are several variants of hemoglobin D such as HbD Punjab (Los Angeles), HbD Iran, HbD Ibadan. Of these variants, HbD Punjab only interacts with HbS, however, the nature of this interaction is not known. [7] HbD has also been reported with other hemoglobinopathies like β-thalassemia without any additional clinical or hematological abnormalities. [2] Earlier studies from Pakistan, Iran, UAE and Mexico have shown that the clinical presentation of HbSD disease cases is similar to that of patients with the severe form of sickle cell anemia. [2, 3] On the other hand, reports from India have shown variable clinical manifestations of HbSD disease. [6, 8] In HbSD disease, HbD does not take part in the sickling process, as patients homozygous for HbD do not sickle. However, an earlier study [9] has indicated that although HbD itself does not polymerize, it facilitates the polymerization of HbS, thus enhancing the severity of the disease. At the same time, the co-inheritance of α-thalassemia and enhanced HbF levels also have an inhibitory effect on the clinical expression of sickle cell disease. Earlier, it has been observed that the inheritance of α-thalassemia with sickle cell anemia and high HbF levels often results in milder clinical manifestations. On the other hand, normal or excess α-globin genes could increase the severity of sickle cell disease. [5] Our patient had a normal α-genotype (αα/αα) along with low HbF levels which could be the possible explanation for the severity in this case.
The Arab-Indian haplotype observed in our patient have been shown to be linked to the β S gene in India. [5] Haplotype1, linked to the β D chromosome has been reported to be the most common one in Mediterraneans as well as in all populations studied worldwide so far. [10] Earlier studies [1, 2, 8] 
